Chau-Chyun Sheu Selected Research

Chau-Chyun Sheu Research Topics

Disease

12	Asthma (Bronchial Asthma) 03/2024 - 01/2014
12	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 05/2006
11	Critical Illness (Critically Ill) 01/2024 - 01/2007
11	Pneumonia (Pneumonitis) 01/2023 - 09/2016
10	Infections 11/2023 - 03/2007
10	Neoplasms (Cancer) 01/2023 - 09/2005
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2024 - 06/2009
7	Healthcare-Associated Pneumonia 11/2023 - 09/2021
5	Human Influenza (Influenza) 01/2024 - 09/2018
5	Lung Neoplasms (Lung Cancer) 12/2021 - 05/2006
4	Idiopathic Pulmonary Fibrosis 09/2022 - 03/2019
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 03/2020
3	Carcinogenesis 12/2021 - 11/2006
2	Bacterial Pneumonia 01/2024 - 10/2021
2	Rare Diseases (Rare Disease) 10/2023 - 06/2008
2	Ventilator-Associated Pneumonia 08/2023 - 01/2023
2	Eosinophilia 01/2022 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 06/2009
2	Insulin Resistance 01/2014 - 05/2010
2	Acute Lung Injury 08/2009 - 06/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2006 - 09/2005
1	Hypertension (High Blood Pressure) 03/2024
1	Pulmonary Alveolar Proteinosis 10/2023
1	Birth Weight (Birth Weights) 06/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 02/2023
1	Disease Progression 02/2023
1	Polymyositis 02/2023
1	Muscle Weakness 02/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	COVID-19 01/2023
1	Hypoxia (Hypoxemia) 06/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Pulmonary Aspergillosis 06/2021
1	Liver Diseases (Liver Disease) 04/2021
1	Chronic Renal Insufficiency 01/2021
1	Latent Tuberculosis 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2020
1	Bacteremia 02/2020
1	Septic Shock (Toxic Shock Syndrome) 02/2020

Drug/Important Bio-Agent (IBA)

9	Carbapenems (Carbapenem Antibiotics)IBA 11/2023 - 01/2018
6	Colistin (Coly-Mycin)FDA Link 01/2023 - 03/2020
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2014
5	SteroidsIBA 01/2023 - 01/2019
5	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 09/2016
4	Messenger RNA (mRNA)IBA 01/2018 - 09/2005
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2005
3	Tigecycline (Tygacil)FDA Link 01/2023 - 01/2019
3	GoldIBA 01/2022 - 10/2021
3	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 10/2017
3	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 12/2021 - 04/2016
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	ORALIT (ORS)IBA 03/2024 - 01/2023
2	Interleukin-5 (Interleukin 5)IBA 01/2024 - 01/2018
2	Immunoglobulin E (IgE)IBA 01/2022 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 11/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2020 - 01/2020
2	Muscarinic AntagonistsIBA 01/2020 - 10/2017
2	LactamsIBA 01/2019 - 01/2018
2	ceftazidime drug combination avibactamIBA 01/2019 - 01/2018
2	AntigensIBA 01/2018 - 05/2007
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2007 - 11/2006
2	hnRNP A2IBA 11/2006 - 01/2006
1	Hormones (Hormone)IBA 03/2024
1	Diethylhexyl Phthalate (DEHP)IBA 03/2024
1	PlasticizersIBA 03/2024
1	phthalic acid (phthalate)IBA 03/2024
1	Surface-Active Agents (Surfactants)IBA 10/2023
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 02/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2023
1	MetalsIBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2023
1	SphingolipidsIBA 01/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2023
1	SDMIBA 01/2022
1	cysteinyl-leukotrieneIBA 12/2021
1	Immunoglobulin G (IgG)IBA 06/2021
1	C-Reactive ProteinIBA 04/2021
1	Thymic Stromal LymphopoietinIBA 01/2021
1	rifapentine (Priftin)FDA Link 01/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021
1	Tryptases (Tryptase)IBA 01/2021
1	Tiotropium Bromide (Spiriva)FDA Link 12/2020
1	CurcuminIBA 11/2020
1	Anti-Infective Agents (Microbicides)IBA 03/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 04/2019
1	nintedanibIBA 03/2019
1	ethyl 4-chloro-3-hydroxybutanoate (CHBE)IBA 01/2019

Therapy/Procedure

15	Therapeutics 11/2023 - 11/2006
7	Artificial Respiration (Mechanical Ventilation) 01/2024 - 11/2006
3	Extracorporeal Membrane Oxygenation 01/2024 - 01/2020
3	Mechanical Ventilators (Ventilator) 08/2023 - 09/2010
3	Length of Stay 01/2022 - 03/2007
2	Nebulizers and Vaporizers (Inhaler) 01/2022 - 12/2020
2	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2021 - 09/2018
1	Critical Care (Surgical Intensive Care) 01/2023
1	Continuous Renal Replacement Therapy 04/2021